Keros Therapeutics (KROS) Non Operating Income (2019 - 2026)
Keros Therapeutics (KROS) reported Non Operating Income of $2.23 million for Q2 2026, down 67.7% from $6.9 million a year earlier.
Powered by 
Analysis
Keros Therapeutics (KROS) Non Operating Income (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Keros Therapeutics' Non Operating Income came in at $20.1 million, down 24.4% year-over-year; for FY2025, it came in at $24.33 million, up 2.3% from FY2024.
- Non Operating Income has increased for three consecutive years, with a five-year compound annual growth rate of 85.0% (FY2020 to FY2025).
- By year, Non Operating Income came in at $23.78 million in FY2024 (+40.3%), $16.95 million in FY2023 (+67.6%), $10.11 million in FY2022 and -$360,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Non Operating Income since Q1 2022.
- Year over year, Non Operating Income gained in five of the last seven quarters, with growth averaging 4.2%.
- The high point for year-over-year Non Operating Income in five years was Q4 2023 (growth of 177.1%); the low point was Q2 2026 (a decline of 67.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Keros Therapeutics | 221.17 Mn | -1.71 Bn | - | 2.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.23 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Sep 30, 2025 | 6.68 Mn |
| Jun 30, 2025 | 6.90 Mn |
| Mar 31, 2025 | 6.45 Mn |
| Dec 31, 2024 | 7.53 Mn |
| Sep 30, 2024 | 5.70 Mn |
| Jun 30, 2024 | 5.18 Mn |
| Mar 31, 2024 | 5.37 Mn |
| Dec 31, 2023 | 6.21 Mn |
| Sep 30, 2023 | 3.84 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 3.07 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 30, 2022 | 4.47 Mn |
| Jun 30, 2022 | 3.46 Mn |
| Mar 31, 2022 | -60,000.00 |
| Dec 31, 2021 | -75,000.00 |
| Sep 30, 2021 | -138,000.00 |
| Jun 30, 2021 | -81,000.00 |
API Access
Keros Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=KROS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "KROS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=KROS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();